Launched in January 2010, MonaVie Mmun (pronounced immune) is the sixth major product from MonaVie LLC of Salt Lake City, UT. Just like MonaVie's other products to date, MonaVie Mmun is an acai berry-based nutritional beverage. This is MonaVie's first entry to the immune health products market. MonaVie Mmun is specifically formulated to promote proper immune function whereas previous products have targeted joint health (Monavie Active), heart health (MonaVie Pulse) and the energy drink market (MonaVie eMV).
MonaVie's previous product launches have rapidly acquired a loyal following. Launched in 2005, the company exceeded 1 billion annual sales in 2009 with only 5 key products – MonaVie Original juice and gel, MonaVie Active juice and gel, MonaVie Pulse juice and gel, MonaVie Kosher and Emv.
Immune Health Products Market
Consumers have moved beyond choosing food and drinks simply to maintain everyday health. They are now seeking to optimize performance and reduce the risk, or delay the onset of diseases with functional food and drinks.
A growing number of products in the food and drinks sector are being marketed as providing consumers with immune health and vitality benefits. These products are designed to help individuals cope with the stresses and strains of modern life. Products claim to protect and defend the immune system, help maintain vitality and inner balance, and reduce or alleviate stress levels.
There is a growing perceived need for food and drink that can meet these requirements, linked to an increasing prevalence of autoimmune diseases in leading economies and more consumers looking to reduce stress experienced on a daily basis. In 2008, nine percent of nutraceutical claims were for immune health products. The area is growing, but science is key to supporting the claims. Immune health and vitality positioning is helping drive growth in brands in the wider $29bn functional foods market and in the $10bn energy food and drinks market.
As many as 1 in 10 consumers suffer from an autoimmune related health condition and prevalence is set to grow in major economies; as well as alleviating symptoms of current sufferers, there is considerable potential for products with preventative qualities. This need is driving the growth and sales of numerous immune health products including MonaVie Mmun.
MonaVie Mmun Product Overview
MonaVie Mmun is a blend of 19 fruits including açai, maqui, grape, apple, acerola, aronia, black currant, elderberry, cranberry, blood orange, sea buckthorn, pear, blueberry, cupuaçu, strawberry, baobab, lingonberry, bilberry, and camu camu. According to the company, these fruits were chosen specifically for their ability to nutritionally support the immune health and overall well being. Many peer-reviewed research papers have been written about the beneficial health properties of fruit in general and about many of the specific fruits selected for the blend.
In addition to the 19 fruits listed above, MonaVie Mmun contains the functional food additive Wellmune WGP developed by Biothera. Wellmune WGP is covered by numerous patents and its efficacy as an immune health product is well documented. Clinical research consistently demonstrates the ability of Wellmune® to naturally enhance human immune responses and provide protection from health challenges related to physical and lifestyle stress. Double-blind, placebo-controlled studies involving marathoners, firefighters and other individuals with stressful lifestyles found that Wellmune reduces incidence of upper respiratory tract infection symptoms and improves a sense of overall health.
Given MonaVie's past success marketing its products person-to-person, the strength of the research behind Wellmune WGP and the media attention to the acai berry, MonaVie mmun is positioned for explosive growth in the immune health products market.
Read more: http://www.articlesbase.com/supplements-and-vitamins-articles/monavie-mmun-in-the-immune-health-products-market-1920884.html#ixzz10Z0nsEVP
http://www.articlesbase.com/supplements-and-vitamins-articles/monavie-mmun-in-the-immune-health-products-market-1920884.html
Wellmune WGP Reduced Cold-Like Symptoms
Wellmune WGP, from Biothera, Eagan, MN, significantly reduced upper respiratory tract infection symptoms in marathon runners while increasing vigor and overall health, according to a study published in the December issue of the Journal of Sports Science and Medicine.
The double-blind, placebo-controlled study included 75 runners (35 men, 40 women) ages 18-53 (mean age 36 years) from the 2007 Carlsbad Marathon in California. During the four-week period following the marathon, subjects consumed Wellmune WGP.
Wellmune WGP is Generally Recognized As Safe (GRAS) by FDA. Clinical research demonstrates that Wellmune WGP activates neutrophils, the most abundant immune cell in the body, to more quickly recognize and kill foreign challenges. Previous published research shows that physical and psychological stress reduces key immune system components, weakening immune defenses and rendering individuals more susceptible to health challenges.
“The data demonstrates the ability of Wellmune WGP to naturally enhance the body’s immune system, resulting in broad protection from stress-induced health challenges,” said Shawn Talbott, PhD, research director for SupplementWatch, Inc., and the study’s principal investigator. “These health benefits aren’t limited to elite athletes; average consumers under daily stress can strengthen their immune systems with Wellmune WGP.”
“The study results provide further support for companies that are marketing or formulating foods and beverages with Wellmune WGP,” said Richard Mueller, Biothera’s CEO. “Consumers want products that deliver real health benefits, and clinical studies consistently demonstrate that Wellmune WGP is safe and efficacious.”
The physical health results demonstrated a significant decrease in upper respiratory tract infection (URTI) symptoms at two and four weeks for subjects taking 250 mg of Wellmune WGP daily. The most common URTI symptoms reported were sore throat, stuffy or runny nose and cough.
When asked how the supplement regimen was affecting their overall health, participants consuming 250 mg of Wellmune WGP daily reported 38% higher scores compared with the placebo group. In addition, the Wellmune subjects reported significantly better scores on a variety of mood states, including a 22% increase in vigor (with 500 mg of Wellmune), 48% reduction in fatigue, 38% reduction in tension and a 38% reduction in confusion.
The study employed a Profile of Mood States (POMS) questionnaire, a validated psychometric test that measures six moods states (vigor, fatigue, tension, confusion, depression and anger) using 65 adjective-based intensity scales.
“The marathoners taking Wellmune WGP experienced fewer symptoms of upper respiratory tract infections so their energy levels and general sense of wellness were higher than the placebo group,” said Dr. Talbott. “Wellmune WGP supports both physical health and a general sense of well-being.”
This summary is taken from the Wellmune corporate website.
Marathon Runner Stress StudyIn a double-blind, placebo-controlled study, marathon runners taking Wellmune WGP® reported significant physical and psychological health benefits.
The physical health results demonstrated a significant decrease in upper respiratory tract infection (URTI) symptoms at two and four weeks for subjects taking 250 mg of Wellmune WGP daily. Sixty-eight percent of runners in the placebo group reported URTI symptoms at 2 weeks compared with only 32% for the group taking Wellmune WGP. At four weeks, 24% of the placebo group reported URTI symptoms compared with 8% of the Wellmune WGP group.
When asked how the supplement regimen was affecting their overall health, participants consuming 250 mg of Wellmune WGP daily reported 38% higher scores compared with the placebo group. In addition, the Wellmune subjects reported significantly better scores on a variety of mood states, including a:
- 22% increase in vigor**
- 48% reduction in fatigue
- 38% reduction in tension
- 38% reduction in stress-related confusion
**500 mgs of Wellmune WGP
Study Design:
The double-blind, placebo-controlled study included 75 marathon runners (35 men, 40 women) ages 18-53 (mean age 36 years) who were recruited from the 2007 Carlsbad Marathon in California. During the four-week period following the marathon, subjects consumed a placebo or Wellmune WGP, a natural carbohydrate that activates key immune cells to more quickly recognize and kill foreign challenges.
The study measured the psychological states of the participants using a Profile of Mood States (POMS) questionnaire. The POMS profile method is a validated psychometric test that measures six primary moods states (vigor, fatigue, tension, confusion, depression and anger). The POMS profile has been used in more than 2,900 health studies.
